PhD Projects in Economics

Micro to Macro: Causal Micro Evidence for Macro Prevention Models

Apply Now

Project Summary

The aim is to generate robust causal evidence on the economic consequences of better health. This will be achieved by exploiting rich, linked administrative health and earnings records to obtain quasi-experimental estimates of how medical interventions and major health events affect workers’ employment, earnings trajectories, and firm-switching decisions over time. The focus is on credible identification: natural policy roll-outs, clinical eligibility thresholds, and diagnostic timing shocks will isolate causal effects that standard cross-sectional studies miss. These high-resolution estimates will form the empirical backbone for evidence-based decisions on prevention subsidies, workplace policy, and social insurance design, and will inform the calibration of macro-prevention models.

naction.

  • Governments require reliable numbers on the economic cost of chronic disease and the payoff to prevention, yet most existing figures rely on correlations or aggregate averages.
  • Accurate micro parameters are essential inputs for agencies such as finance ministries and healthcare technology assessment bodies when assessing the fiscal and welfare implications of health spending.

Why EITis the place
EIT holds secure access to a portfolio of rich data assets that link health and labour‑market histories. Daily interaction with EIT’s prevention, clinical and data‑science teams fosters methodological innovation and rapid policy translation. Oxford’s economics and public‑policy departments add a world‑class setting for labour‑economics training and debate.

‍Potential Supervisors  

  • Supervisors are to be confirmed

Skills Recommended

  • Graduate econometrics, particularly causal inference methods
  • Proficiency in Python, R or Stata for large‑scale data analysis
  • Interest in labour‑ and health‑economics questions

Skills to be Developed

  • Advanced quasi‑experimental techniques (difference‑in‑differences, event studies, regression discontinuity, instrumental variables) applied to administrative micro‑data
  • Translation of empirical findings into policy recommendations and model calibration
  • Communication of results to interdisciplinary audiences in health, economics and public finance

University DPhil Courses 

‍

Supervisors

We are bringing together experts from across the globe, with a shared drive to create lasting impact.

Director of the Oxford Vaccine Group, Ashall Professor of Infection & Immunity

Professor Sir Andrew Pollard

Correlates of Immunity

Director of the Oxford Vaccine Group in the Department of Paediatrics at the University of Oxford.

Principal Scientist, Pathogen Program & Member of the Board of Directors

Professor Gil McVean

Principal Scientist, Pathogen Program & Member of the Board of Directors. Professor of Statistical Genetics at the Department of Statistics and the Nuffield Department of Medicine, University of Oxford.

Principal Scientist, Plant Biology Institute & Member of the Board of Directors

Professor Steve Kelly

Principal Scientist Plant Biology Institute & Member of the Board of Directors at EIT. Professor of Plant Sciences and Senior Research Fellow of the Queens College, University of Oxford.

Executive Director & Principal Scientist

Dr Danilo Jimenez Rezende

AI & Robotics Institute

Executive Director & Principal Scientist for AI & Robotics at EIT. Former Director at Google DeepMind.

Executive Director & Executive Vice President

Dr Matej Macak

AI & Robotics Institute

Executive VP, AI & Robotics at EIT. Chief Technologist at Every Cure.

Principal Scientist, Economics

Professor Andrew Scott CBE

Economics

Principal Scientist of Economics, Economics Professor at University of Oxford. Research covers economics and longevity in aging societies.

Executive Director & Principal Scientist, Materials & Devices for Life Sciences

Professor Hagan Bayley

Materials & Devices for Life Sciences

Professor of Chemical Biology at the University of Oxford. Founder of Oxford Nanopore Technologies. Fellow of the Royal Society.

Founding Director, Generative Biology Institute

Professor Jason Chin

Generative Biology Institute

Founding Director, of the Generative Biology Institute (GBI) and Professor of Chemistry and Chemical Biology at the University of Oxford.

Research Scientist

Dr Ben Chamberlain

AI & Robotics Institute

Research Scientist in the AI & Robotics Institute at EIT. Previously held leadership roles at biotechs Isomorphic Labs and Charm Therapeutics.

Senior Director Device Science

Dr James Clarke

Senior Director of Product Science in the Pathogen Project at EIT.

Principal Investigator

Dr Jérôme Zürcher

Generative Biology Institute

Principal Investigator within GBI at EIT. Former junior research fellow at Trinity College, Cambridge and visiting researcher at the Innovative Genomics Institute at UC Berkeley.

Group Leader

Dr Linna Zhou

Materials & Devices for Life Sciences
Program Co-Lead

Professor Daniela Ferreira

Correlates of Immunity

Professor of Mucosal Immunology and Vaccinology at the Oxford Vaccine Group, Paediatrics Department, University of Oxford.

Senior Director, Science Applications

Professor Justin O'Grady

Pathogen Program

Senior Director of Science Applications in the Pathogen Program at EIT. Honorary Professor at the University of East Anglia.

Senior Group Leader

Professor Yujia Qing

Materials & Devices for Life Sciences

A Senior Group Leader in the Materials & Devices for the Life Sciences program at EIT. An Associate Professor in the Department of Chemistry, University of Oxford

Staff Scientist, AMR and Applied Metagenomics

Dr Vicky Enne

Pathogen Program
Senior Group Leader, Cell Based Production

Professor Lee Sweetlove

Plant Biology Institute